These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17442687)

  • 21. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
    Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
    Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of cytochrome P2C19 in R-warfarin pharmacokinetics and its interaction with omeprazole.
    Uno T; Sugimoto K; Sugawara K; Tateishi T
    Ther Drug Monit; 2008 Jun; 30(3):276-81. PubMed ID: 18520598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of CYP2C19 genotypes on the pharmacokinetics of warfarin enantiomers.
    Uno T; Sugimoto K; Sugawara K; Tateishi T
    J Clin Pharm Ther; 2008 Feb; 33(1):67-73. PubMed ID: 18211619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No pharmacokinetic or pharmacodynamic interaction between rivastatin and warfarin.
    Schall R; Müller FO; Hundt HK; Ritter W; Duursema L; Groenewoud G; Middle MV
    J Clin Pharmacol; 1995 Mar; 35(3):306-13. PubMed ID: 7608323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of nateglinide on the pharmacokinetics and pharmacodynamics of acenocoumarol.
    Sunkara G; Bigler H; Wang Y; Smith H; Prasad P; McLeod J; Ligueros-Saylan M
    Curr Med Res Opin; 2004 Jan; 20(1):41-8. PubMed ID: 14741071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of effect of multiple doses of vortioxetine on the pharmacokinetics and pharmacodynamics of aspirin and warfarin.
    Chen G; Zhang W; Serenko M
    J Clin Pharmacol; 2015 Jun; 55(6):671-9. PubMed ID: 25641606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, on the pharmacokinetics and pharmacodynamics of warfarin.
    Schwartz JI; Liu F; Stroh M; Gipson A; Johnson-Levonas AO; Lasseter KC; Lai E; Wagner JA
    Am J Ther; 2009; 16(3):215-23. PubMed ID: 19454860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children.
    Takahashi H; Ishikawa S; Nomoto S; Nishigaki Y; Ando F; Kashima T; Kimura S; Kanamori M; Echizen H
    Clin Pharmacol Ther; 2000 Nov; 68(5):541-55. PubMed ID: 11103757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacodynamic and stereoselective pharmacokinetic interactions between zileuton and warfarin in humans.
    Awni WM; Hussein Z; Granneman GR; Patterson KJ; Dubé LM; Cavanaugh JH
    Clin Pharmacokinet; 1995; 29 Suppl 2():67-76. PubMed ID: 8620673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer.
    Camidge R; Reigner B; Cassidy J; Grange S; Abt M; Weidekamm E; Jodrell D
    J Clin Oncol; 2005 Jul; 23(21):4719-25. PubMed ID: 16034047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of nebicapone on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
    Almeida L; Falcão A; Vaz-da-Silva M; Nunes T; Santos AT; Rocha JF; Neta C; Macedo T; Fontes-Ribeiro C; Soares-da-Silva P
    Eur J Clin Pharmacol; 2008 Oct; 64(10):961-6. PubMed ID: 18679669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of etoricoxib on the pharmacokinetics of oral contraceptives in healthy participants.
    Schwartz J; Hunt T; Smith WB; Wong P; Larson P; Crumley T; Mehta A; Gottesdiener K; Agrawal N
    J Clin Pharmacol; 2009 Jul; 49(7):807-15. PubMed ID: 19443681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of pharmacokinetic and pharmacodynamic interactions between a smoking cessation therapy, varenicline, and warfarin: an in vivo and in vitro study.
    Burstein AH; Clark DJ; O'Gorman M; Willavize SA; Brayman TG; Grover GS; Walsky RL; Obach RS; Faessel HM
    J Clin Pharmacol; 2007 Nov; 47(11):1421-9. PubMed ID: 17962429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Irbesartan does not affect the steady-state pharmacodynamics and pharmacokinetics of warfarin.
    Mangold B; Gielsdorf W; Marino MR
    Eur J Clin Pharmacol; 1999 Oct; 55(8):593-8. PubMed ID: 10541778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of tolterodine on the anticoagulant actions and pharmacokinetics of single-dose warfarin in healthy volunteers.
    Rahimy M; Hallén B; Narang P
    Arzneimittelforschung; 2002; 52(12):890-5. PubMed ID: 12572529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cilostazol on the pharmacokinetics and pharmacodynamics of warfarin.
    Mallikaarjun S; Bramer SL
    Clin Pharmacokinet; 1999; 37 Suppl 2():79-86. PubMed ID: 10702890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of multiple doses of donepezil HCl on the pharmacokinetic and pharmacodynamic profile of warfarin.
    Tiseo PJ; Foley K; Friedhoff LT
    Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):45-50. PubMed ID: 9839766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of anastrozole on the single-dose pharmacokinetics and anticoagulant activity of warfarin in healthy volunteers.
    Yates RA; Wong J; Seiberling M; Merz M; März W; Nauck M
    Br J Clin Pharmacol; 2001 May; 51(5):429-35. PubMed ID: 11422000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of pharmacokinetic and pharmacodynamic interactions between almorexant and warfarin in healthy subjects.
    Dingemanse J; Hoever P
    Drugs R D; 2013 Jun; 13(2):145-51. PubMed ID: 23737453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of casopitant, a novel NK-1 receptor antagonist, on the pharmacokinetics and pharmacodynamics of steady-state warfarin.
    Kirby LC; Johnson BM; Adams LM; Eberwein DJ; Zhang K; Murray SC; Lates CD; Blum RA; Morris SR
    J Clin Pharmacol; 2010 May; 50(5):566-75. PubMed ID: 20220045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.